This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bender, C. M.
Right arrow Articles by Jones, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bender, C. M.
Right arrow Articles by Jones, P. A.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, October 1999, p. 6690-6698, Vol. 19, No. 10
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Roles of Cell Division and Gene Transcription in the Methylation of CpG Islands

Christina M. Bender, Mark L. Gonzalgo, Felicidad A. Gonzales, Carvell T. Nguyen, Keith D. Robertson, and Peter A. Jones*

Urologic Research Laboratory, USC/Norris Comprehensive Cancer Center, University of Southern California School of Medicine, Los Angeles, California 90089-9181

Received 4 March 1999/Returned for modification 13 April 1999/Accepted 7 July 1999

De novo methylation of CpG islands within the promoters of eukaryotic genes is often associated with their transcriptional repression, yet the methylation of CpG islands located downstream of promoters does not block transcription. We investigated the kinetics of mRNA induction, demethylation, and remethylation of the p16 promoter and second-exon CpG islands in T24 cells after 5-aza-2'-deoxycytidine (5-Aza-CdR) treatment to explore the relationship between CpG island methylation and gene transcription. The rates of remethylation of both CpG islands were associated with time but not with the rate of cell division, and remethylation of the p16 exon 2 CpG island occurred at a higher rate than that of the p16 promoter. We also examined the relationship between the remethylation of coding sequence CpG islands and gene transcription. The kinetics of remethylation of the p16 exon 2, PAX-6 exon 5, c-ABL exon 11, and MYF-3 exon 3 loci were examined following 5-Aza-CdR treatment because these genes contain exonic CpG islands which are hypermethylated in T24 cells. Remethylation occurred most rapidly in the p16, PAX-6, and c-ABL genes, shown to be transcribed prior to drug treatment. These regions also exhibited higher levels of remethylation in single-cell clones and subclones derived from 5-Aza-CdR-treated T24 cells. Our data suggest that de novo methylation is not restricted to the S phase of the cell cycle and that transcription through CpG islands does not inhibit their remethylation.


* Corresponding author. Mailing address: Urologic Research Laboratory, USC/Norris Comprehensive Cancer Center, University of Southern California School of Medicine, 1441 Eastlake Ave., Rm. 8302L, Los Angeles, CA 90089-9181. Phone: (323) 865-0816. Fax: (323) 865-0102. E-mail: jones_p{at}froggy.hsc.usc.edu.


Molecular and Cellular Biology, October 1999, p. 6690-6698, Vol. 19, No. 10
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Ally, M. S., Al-Ghnaniem, R., Pufulete, M. (2009). The Relationship between Gene-Specific DNA Methylation in Leukocytes and Normal Colorectal Mucosa in Subjects with and without Colorectal Tumors. Cancer Epidemiol. Biomarkers Prev. 18: 922-928 [Abstract] [Full Text]  
  • Jin, Z., Hamilton, J. P., Yang, J., Mori, Y., Olaru, A., Sato, F., Ito, T., Kan, T., Cheng, Y., Paun, B., David, S., Beer, D. G., Agarwal, R., Abraham, J. M., Meltzer, S. J. (2008). Hypermethylation of the AKAP12 Promoter is a Biomarker of Barrett's-Associated Esophageal Neoplastic Progression. Cancer Epidemiol. Biomarkers Prev. 17: 111-117 [Abstract] [Full Text]  
  • Jin, Z., Olaru, A., Yang, J., Sato, F., Cheng, Y., Kan, T., Mori, Y., Mantzur, C., Paun, B., Hamilton, J. P., Ito, T., Wang, S., David, S., Agarwal, R., Beer, D. G., Abraham, J. M., Meltzer, S. J. (2007). Hypermethylation of Tachykinin-1 Is a Potential Biomarker in Human Esophageal Cancer. Clin. Cancer Res. 13: 6293-6300 [Abstract] [Full Text]  
  • Lu, R., Wang, X., Chen, Z.-F., Sun, D.-F., Tian, X.-Q., Fang, J.-Y. (2007). Inhibition of the Extracellular Signal-regulated Kinase/Mitogen-activated Protein Kinase Pathway Decreases DNA Methylation in Colon Cancer Cells. J. Biol. Chem. 282: 12249-12259 [Abstract] [Full Text]  
  • van Rietschoten, J. G. I., Verzijlbergen, K. F., Gringhuis, S. I., Kraan, T. C. T. M. v. d. P., Bayley, J.-P., Wierenga, E. A., Jones, P. A., Kooter, J. M., Verweij, C. L. (2006). Differentially methylated alleles in a distinct region of the human interleukin-1{alpha} promoter are associated with allele-specific expression of IL-1{alpha} in CD4+ T cells. Blood 108: 2143-2149 [Abstract] [Full Text]  
  • Ibanez de Caceres, I., Dulaimi, E., Hoffman, A. M., Al-Saleem, T., Uzzo, R. G., Cairns, P. (2006). Identification of novel target genes by an epigenetic reactivation screen of renal cancer.. Cancer Res. 66: 5021-5028 [Abstract] [Full Text]  
  • Yang, A. S., Doshi, K. D., Choi, S.-W., Mason, J. B., Mannari, R. K., Gharybian, V., Luna, R., Rashid, A., Shen, L., Estecio, M. R.H., Kantarjian, H. M., Garcia-Manero, G., Issa, J.-P. J. (2006). DNA Methylation Changes after 5-Aza-2'-Deoxycytidine Therapy in Patients with Leukemia.. Cancer Res. 66: 5495-5503 [Abstract] [Full Text]  
  • Lyko, F., Brown, R. (2005). DNA Methyltransferase Inhibitors and the Development of Epigenetic Cancer Therapies. JNCI J Natl Cancer Inst 97: 1498-1506 [Abstract] [Full Text]  
  • Chan, G. C., Fish, J. E., Mawji, I. A., Leung, D. D., Rachlis, A. C., Marsden, P. A. (2005). Epigenetic Basis for the Transcriptional Hyporesponsiveness of the Human Inducible Nitric Oxide Synthase Gene in Vascular Endothelial Cells. J. Immunol. 175: 3846-3861 [Abstract] [Full Text]  
  • Peng, B., Hodge, D. R., Thomas, S. B., Cherry, J. M., Munroe, D. J., Pompeia, C., Xiao, W., Farrar, W. L. (2005). Epigenetic Silencing of the Human Nucleotide Excision Repair Gene, hHR23B, in Interleukin-6-responsive Multiple Myeloma KAS-6/1 Cells. J. Biol. Chem. 280: 4182-4187 [Abstract] [Full Text]  
  • Cheng, J. C., Weisenberger, D. J., Gonzales, F. A., Liang, G., Xu, G.-L., Hu, Y.-G., Marquez, V. E., Jones, P. A. (2004). Continuous Zebularine Treatment Effectively Sustains Demethylation in Human Bladder Cancer Cells. Mol. Cell. Biol. 24: 1270-1278 [Abstract] [Full Text]  
  • Weisenberger, D. J., Velicescu, M., Cheng, J. C., Gonzales, F. A., Liang, G., Jones, P. A. (2004). Role of the DNA Methyltransferase Variant DNMT3b3 in DNA Methylation. Mol Cancer Res 2: 62-72 [Abstract] [Full Text]  
  • Hisano, M., Ohta, H., Nishimune, Y., Nozaki, M. (2003). Methylation of CpG dinucleotides in the open reading frame of a testicular germ cell-specific intronless gene, Tact1/Actl7b, represses its expression in somatic cells. Nucleic Acids Res 31: 4797-4804 [Abstract] [Full Text]  
  • Cheng, J. C., Matsen, C. B., Gonzales, F. A., Ye, W., Greer, S., Marquez, V. E., Jones, P. A., Selker, E. U. (2003). Inhibition of DNA Methylation and Reactivation of Silenced Genes by Zebularine. JNCI J Natl Cancer Inst 95: 399-409 [Abstract] [Full Text]  
  • Sato, F., Shibata, D., Harpaz, N., Xu, Y., Yin, J., Mori, Y., Wang, S., Olaru, A., Deacu, E., Selaru, F. M., Kimos, M. C., Hytiroglou, P., Young, J., Leggett, B., Gazdar, A. F., Toyooka, S., Abraham, J. M., Meltzer, S. J. (2002). Aberrant Methylation of the HPP1 Gene in Ulcerative Colitis-associated Colorectal Carcinoma. Cancer Res. 62: 6820-6822 [Abstract] [Full Text]  
  • Nguyen, C. T., Weisenberger, D. J., Velicescu, M., Gonzales, F. A., Lin, J. C. Y., Liang, G., Jones, P. A. (2002). Histone H3-Lysine 9 Methylation Is Associated with Aberrant Gene Silencing in Cancer Cells and Is Rapidly Reversed by 5-Aza-2'-deoxycytidine. Cancer Res. 62: 6456-6461 [Abstract] [Full Text]  
  • Cui, H., Fedoroff, N. V. (2002). Inducible DNA Demethylation Mediated by the Maize Suppressor-mutator Transposon-Encoded TnpA Protein. Plant Cell 14: 2883-2899 [Abstract] [Full Text]  
  • Daskalakis, M., Nguyen, T. T., Nguyen, C., Guldberg, P., Kohler, G., Wijermans, P., Jones, P. A., Lubbert, M. (2002). Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment. Blood 100: 2957-2964 [Abstract] [Full Text]  
  • Carty, S. M., Greenleaf, A. L. (2002). Hyperphosphorylated C-terminal Repeat Domain-associating Proteins in the Nuclear Proteome Link Transcription to DNA/Chromatin Modification and RNA Processing. Mol. Cell. Proteomics 1: 598-610 [Abstract] [Full Text]  
  • Bakker, J., Lin, X., Nelson, W. G. (2002). Methyl-CpG Binding Domain Protein 2 Represses Transcription from Hypermethylated pi -Class Glutathione S-Transferase Gene Promoters in Hepatocellular Carcinoma Cells. J. Biol. Chem. 277: 22573-22580 [Abstract] [Full Text]  
  • Majumder, S., Ghoshal, K., Datta, J., Bai, S., Dong, X., Quan, N., Plass, C., Jacob, S. T. (2002). Role of de Novo DNA Methyltransferases and Methyl CpG-binding Proteins in Gene Silencing in a Rat Hepatoma. J. Biol. Chem. 277: 16048-16058 [Abstract] [Full Text]  
  • Velicescu, M., Weisenberger, D. J., Gonzales, F. A., Tsai, Y. C., Nguyen, C. T., Jones, P. A. (2002). Cell Division Is Required for de Novo Methylation of CpG Islands in Bladder Cancer Cells. Cancer Res. 62: 2378-2384 [Abstract] [Full Text]  
  • Liang, G., Gonzales, F. A., Jones, P. A., Orntoft, T. F., Thykjaer, T. (2002). Analysis of Gene Induction in Human Fibroblasts and Bladder Cancer Cells Exposed to the Methylation Inhibitor 5-Aza-2'-deoxycytidine. Cancer Res. 62: 961-966 [Abstract] [Full Text]  
  • Liang, G., Chan, M. F., Tomigahara, Y., Tsai, Y. C., Gonzales, F. A., Li, E., Laird, P. W., Jones, P. A. (2002). Cooperativity between DNA Methyltransferases in the Maintenance Methylation of Repetitive Elements. Mol. Cell. Biol. 22: 480-491 [Abstract] [Full Text]  
  • Singal, R., vanWert, J. M. (2001). De novo methylation of an embryonic globin gene during normal development is strand specific and spreads from the proximal transcribed region. Blood 98: 3441-3446 [Abstract] [Full Text]  
  • Xiong, Z., Wu, A. H., Bender, C. M., Tsao, J.-L., Blake, C., Shibata, D., Jones, P. A., Yu, M. C., Ross, R. K., Laird, P. W. (2001). Mismatch Repair Deficiency and CpG Island Hypermethylation in Sporadic Colon Adenocarcinomas. Cancer Epidemiol. Biomarkers Prev. 10: 799-803 [Abstract] [Full Text]  
  • Pao, M. M., Tsutsumi, M., Liang, G., Uzvolgyi, E., Gonzales, F. A., Jones, P. A. (2001). The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells. Hum Mol Genet 10: 903-910 [Abstract] [Full Text]  
  • Tada, Y., Wada, M., Kuroiwa, K., Kinugawa, N., Harada, T., Nagayama, J., Nakagawa, M., Naito, S., Kuwano, M. (2000). MDR1 Gene Overexpression and Altered Degree of Methylation at the Promoter Region in Bladder Cancer during Chemotherapeutic Treatment. Clin. Cancer Res. 6: 4618-4627 [Abstract] [Full Text]  
  • Robertson, K. D., Keyomarsi, K., Gonzales, F. A., Velicescu, M., Jones, P. A. (2000). Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G0/G1 to S phase transition in normal and tumor cells. Nucleic Acids Res 28: 2108-2113 [Abstract] [Full Text]  
  • Salem, C., Liang, G., Tsai, Y. C., Coulter, J., Knowles, M. A., Feng, A.-C., Groshen, S., Nichols, P. W., Jones, P. A. (2000). Progressive Increases in de Novo Methylation of CpG Islands in Bladder Cancer. Cancer Res. 60: 2473-2476 [Abstract] [Full Text]